DGAP-News: Apricus Biosciences Launches Commercialization Arm With Definitive Agreement to Acquire Topotarget USA
Apricus Biosciences, Inc.
16.12.2011 14:00
—————————————————————————
First Acquisition by Apricus Bio of an FDA Approved and Marketed US Drug
SAN DIEGO, 2011-12-16 14:00 CET (GLOBE NEWSWIRE) —
Apricus Biosciences, Inc. (–Apricus Bio– or the –Company–) (Nasdaq:APRI)
announced today a definitive agreement to acquire Topotarget USA, Inc.
(–Topotarget USA–), a subsidiary of Topotarget A/S, a public Danish company
(–Topotarget A/S–). Topo